IGF1 and colorectal carcinoma: In particular, CRC and Type 2 diabetes (T2DM) share pathophysiological pathways involving hyperglycemia, hyperinsulinemia, and insulin resistance through the regulation of insulin‐like growth factor (IGF) signaling pathways.8